SCHEMBL741526

SCHEMBL741526

CC(C)(NC(=O)c1cc2c(NC(=O)c3cccs3)n[nH]c2s1)c1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
KDM4E B2RXH2 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
AURKA O14965 1/20 0.40
POLB P06746 1/20 0.39
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.38
ABL1 P00519 4/20 0.38
BCR P11274 2/20 0.38
MEN1 O00255 2/20 0.37
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741356 0.91 KMT2A (0.43) RAB9ANPC1SMN1; SMN2KDM4ENFKB1
SCHEMBL743308 0.90 AURKA (0.48) RAB9ANPC1SMN1; SMN2KDM4EAURKA
SCHEMBL739893 0.88 RAB9A (0.48) RAB9ANPC1SMN1; SMN2KDM4EAURKA
SCHEMBL741622 0.86 RAB9A (0.41) RAB9ANPC1SMN1; SMN2KDM4ENFKB1
SCHEMBL1779010 0.84 RXFP1 (0.48) RAB9ANPC1SMN1; SMN2KDM4EAURKA
SCHEMBL741896 0.84 RAB9A (0.47) RAB9ANPC1SMN1; SMN2KDM4EAURKA
SCHEMBL742124 0.84 AURKA (0.48) RAB9ANPC1SMN1; SMN2AURKAPOLB
SCHEMBL739851 0.81 AURKA (0.65) AURKAABL1BCR
SCHEMBL739810 0.81 APLNR (0.47) RAB9ANPC1SMN1; SMN2POLBKMT2A
SCHEMBL741231 0.80 USP36 (0.45) RAB9ANPC1AURKAKMT2AABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed